Creative Biolabs Builds a Smarter Path to Complement Therapeutics Research
In the world of drug development, the leap from concept to clinic is often a long and winding road.
But Creative Biolabs is quietly reshaping that journey—one assay, one chip, one insight at a time.
Their latest offerings are more than just tools, built with scientists in mind who are navigating the early stages of therapeutic discovery.
Featured Services
Creative Biolabs now offers a series of featured services that accelerate complementary therapeutic development.
- The CH50 functional test kit is a hemolysis-based assay that quantifies the activity of the classical pathway of the complement system.
"This kit isn't just giving you data—it's giving you confidence," said a senior scientist with Creative Biolabs. "We've seen consistent, reproducible results in the lab, so it's a good early-stage screening tool.
Author summary: Creative Biolabs accelerates complement therapeutics research.
More News
- First Duel Night Abyss Figure Is Based on Psyche
- SJHN Daily: Celebrini Named NHL First Star of the Week
- LPD searches for motor vehicle theft suspect
- Annual Old Town Gazebo 'Day of the Dead' Event Cancelled
- Dear ASEAN Leaders: Trumpism Is Not A Temporary Phenomenon. Here’s Why?
- Giving States Waivers From Accountability Is a Dangerous Step Backward for Kids
- Lightning place forward Mitchell Chaffee on waivers
- It’s All About Dance Music as Dexter Community Band Kicks Off its 2025-26 Season - The Sun Times News
- Frogs help Fred Hutch find the shape of small things
- GSK Agrees to $357 Million Exclusive License Agreement for Syndivia’s AntiBody-Drug Conjugate | PharmExec